Evidence map›Paper›PMID 40854928›Full record

ArticleScientific reports2025

Investigating the role of molecular coating in human corneal endothelial cell primary culture using artificial intelligence-driven image analysis.

Gauthier Travers, Louise Coulomb, Inès Aouimeur, Zhiguo He, Guillaume Bonnet, Edouard Ollier, Yann Gavet, Anaick Moisan, Philippe Gain, Gilles Thuret and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gauthier Travers *Laboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Louise Coulomb *Laboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Inès AouimeurLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Zhiguo HeLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Guillaume BonnetLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Edouard OllierClinical Research Unit, University Hospital, Saint-Étienne, France.
Yann GavetEcole Nationale Supérieure des Mines Saint-Etienne, Université de Lyon, CNRS, UMR 5307 LGF, Centre SPIN, Saint-Etienne, 42023, France.
Anaick MoisanCell Therapy Unit, Auvergne Rhône Alpes French Blood Center, Saint- Ismier, France.
Philippe GainLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Gilles ThuretLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France.
Corantin MaurinLaboratory Biology, Engineering and Imaging for Ophthalmology (BiiO), Faculty of Medicine, Health Innovation Campus, Jean Monnet University, Saint-Étienne, France. corantin.maurin@univ-st-etienne.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The monolayer of approximately 300,000 human corneal endothelial cells (hCECs) on the posterior surface of the cornea is essential to maintain transparency but is non-self-regenerative. Corneal blindness can currently only be treated by corneal transplantation, hindered by a global donor shortage, highlighting the need for developing tissue and/or cell therapy. The mass production of these advanced therapy medicinal products requires obtaining high-yield, high-quality endothelial cell cultures characterized by hexagonal shape, low size variability, and high endothelial cell density (ECD). Among the usual critical quality attributes which combine the expression of differentiation markers, ECD and cell morphological parameters, the latter are not optimally measured in vitro by conventional image analysis which poorly recognizes adherent cultured cells. We developed a high-performance automated segmentation using Cellpose algorithm and an original analysis method, improving the calculation of classical morphological parameters (coefficient of variation of cell area and hexagonality) and introducing new parameters specific to hCECs culture in vitro. Considering the importance of the extracellular matrix in vivo, and the panel of molecules available for coating cell culture plastics, we used these new tools to perform a comprehensive comparison of 13 molecules (laminins and collagens). We demonstrated their ability to discriminate subtle differences between cultures.

Indexed as

Artificial IntelligenceEndothelial CellsEndothelium, CornealImage Processing, Computer-AssistedPrimary Cell CultureAlgorithmsCell Culture TechniquesCells, CulturedCollagenExtracellular MatrixHumansLamininCollagenLamininCell therapyEndothelial cell density (ECD)High-performance automatic segmentationHuman corneal endothelial cells (hCECs)ImmunohistochemistryMolecular coatingPrimary cell cultureTissue-engineered endothelial keratoplasty (TEEK)

Identifiers

PMID40854928
PMCPMC12379294

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.